Shire Plc has highlighted the growth of its commercial and clinical-stage portfolios in a report on the 2015 first quarter, which showed an 11% rise in revenue to $1.49 billion, and a 55% rise in operating income to $475 million. ---Subscribe to MedNous to access this article--- Company News
